Persistent Asset Partners LTD Terns Pharmaceuticals, Inc. Transaction History
Persistent Asset Partners LTD
- $135 Billion
- Q2 2025
A detailed history of Persistent Asset Partners LTD transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Persistent Asset Partners LTD holds 59,797 shares of TERN stock, worth $1.05 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
59,797
Previous 12,807
366.91%
Holding current value
$1.05 Million
Previous $35.3 Million
531.01%
% of portfolio
0.17%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding TERN
# of Institutions
133Shares Held
84.3MCall Options Held
173KPut Options Held
89.5K-
Soleus Capital Management, L.P. Greenwich, CT8.17MShares$143 Million2.36% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.56MShares$133 Million1.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.5MShares$131 Million0.99% of portfolio
-
Morgan Stanley New York, NY7.25MShares$127 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.9MShares$121 Million5.45% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $660M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...